Gonyer David A
President and CEO at Evoke Pharma Inc
- Sold, on record
- $210k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Dec 14, 2020
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Evoke Pharma IncPresident and CEO
Sales by reason
0
Routine
1
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Dec 14, 2020Plan not stated
Sold 17.5% of their holdings
$210k72,000 shares at $2.91
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Feb 10, 2023 | Evoke Pharma Inc | CEO | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| Feb 2, 2022 | Feb 4, 2022 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 175,000 | 175,000 | SEC | ||
| Jan 27, 2021 | Jan 29, 2021 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 415,000 | 415,000 | SEC | ||
| Dec 14, 2020 | Dec 14, 2020 | Evoke Pharma Inc | President and CEO | Sold | 72,000 | $2.91 | $210k | 339,782 | SEC |
| Dec 9, 2020 | Dec 11, 2020 | Evoke Pharma Inc | President and CEO | Exercised or settledStock Option (Right to Buy) | 72,000 | 0 | SEC | ||
| Dec 9, 2020 | Dec 11, 2020 | Evoke Pharma Inc | President and CEO | Exercised options | 72,000 | $0.40 | $29k | 411,782 | SEC |
| Sep 1, 2020 | Sep 2, 2020 | Evoke Pharma Inc | President and CEO | Other | 20,238 | $1.05 | $21k | 339,782 | SEC |
| Feb 28, 2020 | Mar 3, 2020 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 325,000 | 325,000 | SEC | ||
| Jun 17, 2019 | Jun 19, 2019 | Evoke Pharma Inc | President and CEO | Returned to the companyStock Option (Right to Buy) | 890,687 | 0 | SEC | ||
| Jun 17, 2019 | Jun 19, 2019 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 668,015 | 168,750 | SEC | ||
| Feb 6, 2019 | Feb 8, 2019 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Aug 31, 2018 | Sep 5, 2018 | Evoke Pharma Inc | President and CEO | Other | 6,901 | $1.63 | $11k | 319,544 | SEC |
| Apr 26, 2018 | Apr 27, 2018 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Aug 31, 2017 | Sep 5, 2017 | Evoke Pharma Inc | President and CEO | Other | 8,240 | $2.15 | $18k | 312,643 | SEC |
| Feb 28, 2017 | Mar 2, 2017 | Evoke Pharma Inc | President and CEO | Other | 12,000 | $1.60 | $19k | 304,403 | SEC |
| Feb 8, 2017 | Feb 8, 2017 | VRDN | Director | Exercised or settledStock Option (Right to Buy) | 1,200 | 0 | SEC | ||
| Feb 8, 2017 | Feb 8, 2017 | VRDN | Director | Exercised options | 1,200 | $7.65 | $9k | 1,899 | SEC |
| Jan 25, 2017 | Jan 27, 2017 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Jun 15, 2016 | Jun 20, 2016 | VRDN | Director | AwardedStock Option (Right to Buy) | 18,000 | 18,000 | SEC | ||
| Mar 1, 2016 | Mar 1, 2016 | Evoke Pharma Inc | President and CEO | Other | 4,669 | $2.90 | $14k | 292,403 | SEC |
| Feb 5, 2016 | Feb 5, 2016 | Evoke Pharma Inc | President and CEO | Returned to the companyStock Option (Right to Buy) | 174,250 | 0 | SEC | ||
| Feb 5, 2016 | Feb 5, 2016 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 130,687 | 60,000 | SEC | ||
| Jan 28, 2016 | Jan 29, 2016 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 85,000 | 85,000 | SEC | ||
| Aug 31, 2015 | Sep 2, 2015 | Evoke Pharma Inc | President and CEO | Other | 4,023 | $3.31 | $13k | 287,734 | SEC |
| Aug 6, 2015 | Aug 10, 2015 | VRDN | Director | Exercised or settledRestricted Stock Units | 4,125 | 0 | SEC | ||
| Aug 6, 2015 | Aug 10, 2015 | VRDN | Director | Exercised options | 4,125 | 5,500 | SEC | ||
| Aug 6, 2015 | Aug 10, 2015 | VRDN | Director | AwardedStock Option (Right to Buy) | 18,000 | 18,000 | SEC | ||
| Aug 6, 2015 | Aug 10, 2015 | VRDN | Director | Awarded | 5,000 | 10,500 | SEC | ||
| Jul 17, 2015 | Jul 21, 2015 | VRDN | Director | Exercised or settledRestricted Stock Units | 1,375 | 4,125 | SEC | ||
| Jul 17, 2015 | Jul 21, 2015 | VRDN | Director | Exercised options | 1,375 | 1,375 | SEC | ||
| Mar 6, 2015 | Mar 9, 2015 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 80,000 | 80,000 | SEC | ||
| Feb 27, 2015 | Mar 2, 2015 | Evoke Pharma Inc | President and CEO | Other | 2,711 | $4.75 | $13k | 283,711 | SEC |
| Jul 17, 2014 | Jul 21, 2014 | VRDN | Director | AwardedStock Option (right to buy) | 11,500 | 5,500 | SEC | ||
| Mar 31, 2014 | Feb 6, 2015 | Evoke Pharma Inc | President and CEO | Other | 164,000 | 281,000 | SEC | ||
| Mar 31, 2014 | Feb 6, 2015 | Evoke Pharma Inc | President and CEO | Other | 164,000 | 281,000 | SEC | ||
| Dec 2, 2013 | Dec 3, 2013 | Evoke Pharma Inc | President and CEO | AwardedStock Option (Right to Buy) | 94,250 | 94,250 | SEC |
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | Dec 14, 2020 | Evoke Pharma Inc | President and CEO | Form 4 sale | 72,000 | $210k | 17.5% | Plan not stated | SEC |